Status:
COMPLETED
Knee Steroid Injection and Blood Sugar Signatur
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
Foundation for Physical Medicine and Rehabilitation
Conditions:
Diabetes
Knee Osteoarthritis
Eligibility:
All Genders
18+ years
Brief Summary
A prospective, observational study assessing the relationship between HbA1c level and the post-injection blood glucose signature. Participants will be non-diabetic, pre-diabetic, non-insulin dependent...
Eligibility Criteria
Inclusion
- Patients at the Parkland Outpatient Clinic
- Indication for unilateral knee joint steroid injection for the treatment of knee joint osteoarthritis
Exclusion
- Less than 18 years old
- HbA1c \> 12.0%
- steroid exposure in the 3 months prior to Visit 1
- 3 or more steroid injections in the preceding 12 months
- known contraindication to steroid injection (adverse reaction or allergy, active infection, INR \> 3.0)
- lack of improvement with prior knee steroid injection
- change in diabetic medication regimen in the last 1 month
- significant change in diet within the last 1 month
- current use of aspirin
- allergy to adhesive
- planned MRI, XR, or CT during the 2-week study period
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04317404
Start Date
November 1 2020
End Date
November 30 2022
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Parkland Hospital
Dallas, Texas, United States, 75235